Erythropoietin receptor function and expression in epithelial ovarian carcinoma
- PMID: 16051335
- DOI: 10.1016/j.ygyno.2005.06.038
Erythropoietin receptor function and expression in epithelial ovarian carcinoma
Abstract
Objective: Our objectives were to determine if the erythropoietin receptor (EpoR) has increased expression in epithelial ovarian carcinoma, and if erythropoietin (Epo) confers malignant properties to ovarian cancer cell lines.
Methods: A Western blot analysis of protein lysates from normal ovarian surface epithelial cells and ovarian cancer cell lines was performed. In addition, immunohistochemical (IHC) staining for EpoR in tissue specimens of normal, low malignant potential tumor, and epithelial ovarian carcinoma was performed. Epo effect on ovarian cancer cell lines was investigated by a cytotoxicity assay using a cell line with high (OVCAR3) and low (SKOV3) EpoR expression.
Results: Western blot analysis revealed increased expression of EpoR in multiple ovarian cancer cell lines. IHC staining revealed limited EpoR expression in benign ovarian tissue and increased levels in ovarian low malignant potential (LMP) tumor and carcinoma. This difference between benign ovarian tissue and carcinoma was found to be statistically significant using a quantitative scoring system. In addition, a cytotoxicity assay with paclitaxel and cisplatin revealed an attenuation of cytotoxic effects.
Conclusion: Increased EpoR expression in ovarian LMP tumors and carcinoma is demonstrated by Western blot analysis and IHC staining. Furthermore, adversely effects sensitivity to cisplatin in the ovarian cancer cell lines. These data add to the growing body of evidence suggesting possible detrimental effects of erythropoietin.
Similar articles
-
High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.Hum Pathol. 2006 Jul;37(7):906-13. doi: 10.1016/j.humpath.2006.02.017. Epub 2006 May 26. Hum Pathol. 2006. PMID: 16784992
-
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.Hum Pathol. 2010 Feb;41(2):255-61. doi: 10.1016/j.humpath.2009.07.019. Epub 2009 Nov 6. Hum Pathol. 2010. PMID: 19896693
-
The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.Gynecol Oncol. 2007 Mar;104(3):714-20. doi: 10.1016/j.ygyno.2006.10.016. Epub 2007 Jan 3. Gynecol Oncol. 2007. PMID: 17204312
-
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.Am J Surg Pathol. 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. Am J Surg Pathol. 2006. PMID: 17001150 Review.
-
Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors.Med Electron Microsc. 2004 Mar;37(1):37-44. doi: 10.1007/s00795-003-0189-0. Med Electron Microsc. 2004. PMID: 15057603 Review.
Cited by
-
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD007303. doi: 10.1002/14651858.CD007303.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588423 Free PMC article.
-
Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.PLoS One. 2013 Jun 25;8(6):e67142. doi: 10.1371/journal.pone.0067142. Print 2013. PLoS One. 2013. PMID: 23825635 Free PMC article.
-
Expression of the erythropoietin receptor by germline-derived cells - further support for a potential developmental link between the germline and hematopoiesis.J Ovarian Res. 2014 Jun 17;7:66. doi: 10.1186/1757-2215-7-66. eCollection 2014. J Ovarian Res. 2014. PMID: 24982693 Free PMC article.
-
The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.Sci Rep. 2017 Aug 29;7(1):9689. doi: 10.1038/s41598-017-08766-5. Sci Rep. 2017. PMID: 28851888 Free PMC article.
-
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.Am J Pathol. 2009 Apr;174(4):1504-14. doi: 10.2353/ajpath.2009.080592. Epub 2009 Mar 5. Am J Pathol. 2009. PMID: 19264915 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials